Skip to content

Effects of Physical Treatment on Postural Stability in Benign Paroxysmal Positional Vertigo (BPPV) Patients

Epley Maneuver vs. Semont Maneuver for Benign Paroxysmal Positional Vertigo (BPPV): Evaluating Treatment Effectiveness by Postural Stability - a Double Blinded Randomized Controlled Trial.

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00978809
Enrollment
0
Registered
2009-09-17
Start date
2009-09-30
Completion date
2010-06-30
Last updated
2015-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Paroxysmal Positional Vertigo

Keywords

BPPV, postural stability, Epley, Semont

Brief summary

The propose of this study is to compare two methods of physical treatment for benign paroxysmal positional vertigo, by evaluating treatment effects on postural stability. The trail design is a double blinded randomized controlled trail, with each patient going through three evaluations: before treatment, 1 week after treatment and 60 days after treatment.

Interventions

Sponsors

Ben-Gurion University of the Negev
CollaboratorOTHER
Assuta Hospital Systems
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

* medical referral for treating vertigo * subject has short episodes of rotatory vertigo (up to 1 minute) * subject has positive Hallpike-Dix test with typical nystagmus * repeated Hallpike-dix test will show fatigability

Exclusion criteria

* Hallpike-Dix test produces vertigo without nystagmus * subject has BPPV of the horizontal or anterior semi-circular canal * subject has other known vestibular or neurologic condition * subject has nystagmus of a different type * subject has a cervical spine problem which prevents the utilization of Epley or Semont maneuvers * subject is unable to stand for 1 minute * subject gets pharmacologic treatment for vertigo while doing the postural stability evaluation * subject is under 18 years old or a pregnant female or cannot obtain informed concent

Design outcomes

Primary

MeasureTime frame
postural stability60 days post treatment

Secondary

MeasureTime frame
subjective vertigo60 days post treatment

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026